Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Botanical and Plant Derived Drugs Market, by Source (Plant, Algae, Macroscopic fungi, and Others), by Dosage Form (Pills, Tablets, Capsules, and Injection), by Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, and Respiratory Diseases), by Region - Global Forecast to 2026

Published Date : Jun 2018

Botanical and Plant Derived Drugs Market - Global Industry Insights The botanical and plant derived drugs are obtained from medicinal plants, which contain algae, microscopic fungi or any vegetable material.

Coherent Market Insights
Chronic Kidney Disease Drugs Market, by Drug Class (ACE Inhibitors, B- Blockers, Calcium Channel Blockers, Diuretics, Erythropoiesis-Stimulating Agents (ESAs), and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Forecast to 2026

Published Date : Jun 2018

Chronic Kidney Disease Drugs Market – Insights Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and exc

Coherent Market Insights
Pain Management Drugs Market, by Drug Class (Opioids, NSAIDs, Anticonvulsants, Antidepressants, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Forecast to 2026

Published Date : May 2018

Pain Management Drugs Market – Insights Pain management medications are specific drug classes, which have pharmacological actions on pain receptors and work against the pain symptoms. These medications

Coherent Market Insights
Herbal Medicinal Products Market, by Product Type (Ayurvedic Medicines, Homeopathic Medicines, Chinese Medicines and Aromatherapy), by Dosage Form (Capsules/Tablets, Syrups, Powders, Ointment, others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and others), and by Region - Global Forecast to 2025

Published Date : May 2018

Herbal Medicinal Products Market Insights- No chemical, high safety The herbal medicines product are the first choice among people to avoid adverse health effects. According to the Council for Scientific and

Coherent Market Insights
Dementia Drugs Market, by Drug Class (MAO Inhibitors, Cholinesterase Inhibitors, and Glutamate Inhibitors), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and by Geography - Global Forecast to 2026

Published Date : May 2018

Dementia Drugs Market – Insights Dementia is a form of disease that affects the functioning of the brain resulting in decline in memory or other thinking skills. Alzheimer’s disease is the most co

Coherent Market Insights
Small Molecule Prefilled Syringes Market, by Drug Class (Cardiovascular Drugs, Neurology Drugs, Analgesics, Adjuvants, and Others), By Material (Glass, and Plastic & Polymer) and Region - Global Trends and Forecast to 2025

Published Date : May 2018

Small Molecule Prefilled Syringes Market Insights Small molecule prefilled syringes are pharmaceutical preparations of small molecule drugs that are sold in prefilled syringes. Small molecule prefilled syring

Coherent Market Insights
Alzheimer’s Drugs Market, by Drug (Donepezil, Rivastigmine, Galantamine and Memantine), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region - Global Forecast to 2025

Published Date : Mar 2018

Alzheimer’s Drugs Market - Young Prospect for Aging Patient Alzheimer’s is a form of dementia, which affect behavior, thinking, and memory of patient. The progression of disease is slow and it deg

Coherent Market Insights
Acute Otitis Media Treatment Market, by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End User (Hospitals, Retail pharmacies, and Online pharmacies) and Region - Global Trends, and Forecast to 2025

Published Date : Feb 2018

Acute Otitis Media Treatment Market - Insights Acute otitis media (AOM) is a type of ear infection in which air-filled space behind the eardrum (the middle ear) is infected and causes pain and general symptom

Coherent Market Insights
Facial Injectables Market, by Product Type (Dermal Fillers, and Anti-wrinkle Injection), by Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others) by End User (Hospitals, Dermatology Centers, Beauty Clinics, and Others), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Facial Injectables Market – Restoring the Radiance of Youth Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial i

Coherent Market Insights
Empty Capsules Market, by Product Type (Gelatin Capsules (Porcine, Bovine, Bone Meal), Non-Gelatin Capsules (HPMC, Pullulan)), By Application (Antibiotics, Vitamins, Anti-Inflammatory, Anti-Anemic and Others), By End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers and Others), and Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Empty Capsules Market - Insights Capsules offer a viable alternative to tablets as an oral delivery of therapeutic compounds. Empty capsules are oral dosage forms, which based on the type of manufacturing mat

Coherent Market Insights
Multiple Sclerosis Therapeutics Market, by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents and Others), by Route of Administration (Oral and Injection), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal c

Coherent Market Insights
Hereditary Angioedema Market, by Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), by Route of Administration (Subcutaneous, Intravenous, and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce) and by Region - Global Trends and Forecast till 2025

Published Date : Feb 2018

Hereditary Angioedema Market – Efficient Disease Management for Orphan Disease Hereditary angioedema (HAE) is a rare disorder related with the immune system. The life-threatening condition is caused du

Coherent Market Insights
Sucralfate Market, by Formulation (Tablet and Liquid), by Indication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), and Other Indications), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Sucralfate is the generic form of the brand-name drug, Carafate. It is a prescription medicine used to treat ulcers of the upper gastrointestinal tract, peptic ulcer disease, and to prevent reoccurrence of ulcers. Sucralfate is a hydroxy aluminum salt of sucrose octas

Coherent Market Insights
Streptozocin Market by Product Type (Powder and Solution), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Streptozocin is a drug approved by U.S. Food and Drug Administration (USFDA) for the treatment of pancreatic islet cells cancer. Streptozocin is classified as an alkylating agent, which produces anti-cancer effects by causing a chemical reaction that damages the DNA i

Coherent Market Insights
Quercetin Dihydrate Market, by Product Type (Powder and Solution), by Application, (Atherosclerosis, Chronic Infections, Cosmetics, Nutraceuticals, Allergy & Inflammation, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Quercetin is a plant flavonoid found in variety of fruits, vegetables, grains, and leaves. It is used as an ingredient in nutritional supplements and prepared foods. Quercetin dihydrate is formed by removing moisture from quercetin, which is more effective and highly

Coherent Market Insights
Poliomycetes Vaccine in Dragee Candy Market, by Vaccine Type (Type I Poliovirus Infection, and Type II Poliovirus Infection), by Application (Hospitals, Clinics, and Medical Centers), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Poliomyelitis is an acute communicable disease of humans caused by human enterovirus called poliovirus. Poliovirus is transmitted from one person to another by oral contact, with secretions or fecal material from an infected person. Wild type poliovirus cases have bee

Coherent Market Insights
Pharma Grade Magnesium Trisilicate Market by Product Type (heavy and Light), by Application (Pharmaceuticals, Cosmetics, Food, and Industrial), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Magnesium trisilicate is an inorganic compound that is used as Active Pharmaceutical Ingredient (API) in an antacid formulations for the treatment of peptic ulcers. The gelatinous silicon dioxide is formed by the reaction of magnesium trisilicate with gastric contents

Coherent Market Insights
Polyether Antibiotics Market, by Drug (Lasalocid, Monesin, Salinomycin, Narasin, and Others), by Application (Coccidiosis, Growth Promotion in Cattles, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jul 2019

Polyether ionophores antibiotics group consists of natural, biologically active substances produced by Streptomyces spp species. Polyether antibiotics have antifungal, antibacterial, antiviral, antiparasitic, and tumor cell cytotoxicity properties. Commercially, polye

Coherent Market Insights
Tacrolimus Market, by Product Type (Tacrolimus Capsules & Tablets, Tacrolimus Ointment, and Tacrolimus Injection), by Application (Immunosuppression, Dermatitis, and Others), by End User (Organ Transplant Centers, Hospitals, and Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jul 2019

Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection. Tacrolimus inhibits the activation of serine-threonine phosphatase, calcineurin, in T lymphocytes. This suppresses T lymphocyte activation and the subs

Coherent Market Insights
Codeine Market, by Indication (Pain Management, and Cough Management), by Age Group (Adult and Pediatric), by Dosage Form (Tablet, Capsule and Solution/Syrup), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jul 2019

Codeine is a drug of class known as opioids, widely used in the treatment and management of mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu (when combined with antihistamines and decongestants). Opioids interact with opioid recepto

Coherent Market Insights
Nitric Oxide Synthase (NOS) Brain Market, by Product Type (Neuronal NOS (nNOS), Endothelial NOS (eNOS), and Inducible NOS (iNOS)), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jul 2019

Nitric oxide synthases (NOS) are group of enzymes, which convert L-arginine to L-citrulline and produce nitric oxide (NO). Nitric oxide synthases enzymes exhibit a bidomain structure homologous to cytochrome P450 reductase. There are three isoforms of NOS titled accor

Coherent Market Insights
Ramosetron Hydrochloride Market by Indication (Motion Sickness, Irritable Bowel Syndrome, Cancer Chemotherapy associated Nausea and Vomiting, and, Diarrhoea), by Application (Hospitals, Clinics, and Home Care), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Ramosetron hydrochloride, an anti-emetic drug, is prescribed for the treatment of diarrhoea-predominant irritable bowel syndrome in adults. Ramosetron hydrochloride is also prescribed for the treatment and management of postoperative nausea and/or vomiting and also as

Coherent Market Insights
Plasminogen Activator Inhibitor Market by Product Type 1 (Plasminogen Activator Inhibitor Type 1 (PAI-1), and Plasminogen Activator Inhibitor Type 2 (PAI-2)), by Application (Fibrinolysis, Cardiac Fibrosis, and Post-operative Wound Hematomas), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Plasminogen activator inhibitors also known as Serpin E1 is a protein present in the body whose elevated levels are responsible for thrombosis and atherosclerosis. (Plasminogen Activator Inhibitor Type 1 (PAI-1) is mainly secreted by the endothelium (cells lining blood vessels), and adipose tissu

Coherent Market Insights
Microneedle Flu Vaccine Market, by Vaccine Type (Trivalent Flu Vaccine and Quadrivalent Flu Vaccine), by Virus Type (Influenza Virus Type A and Influenza Virus Type B), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) — Size, Share, Outlook, and Opportunity Analysis, 2018–2026

To Be Published : Jul 2019

Vaccine is one of the most important biologic product used to prevent from infection of various diseases such as seasonal influenza, hepatitis, polio, diphtheria, Japanese encephalitis, measles, meningococcal disease, tetanus, haemophilus influenza type b, whooping co

Coherent Market Insights
Sulfachloropyridazine Sodium Market by Patient Type (Cows, Pigs, Chickens, Cattles, and Pediatrics), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jul 2019

Sulfachloropyridazine sodium is a sulfonamide antibiotic used to study kinetics and reaction pathways. Also, it is used to treat acute Urinary Tract Infections (UTIs) in pediatric patients. Sulfachloropyridazine sodium blocks the synthesis of dihydrofolic acid by inhi

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.